Home » Topics » Regulatory

Regulatory
RSS

Expanded use of acellular DTP vaccine approved

Dec. 31, 1996

Nutropin cleared for marketing

Dec. 31, 1996

Bayer antibacterial cleared for wider use by FDA

Dec. 31, 1996

FDA clears oral monotherapy for PID

Dec. 31, 1996

Bayer launches sustained-release calcium antagonist in U.K.

Dec. 31, 1996

Andrx licenses chemoprotective agent to Asta

Dec. 30, 1996

Company Profile: Celgene Corporation

Dec. 30, 1996

Novel antihistamine formulation approved by FDA

Dec. 24, 1996

NanoSystems to develop novel formulation of HIV protease inhibitor

Dec. 23, 1996

First Rx for oral ulcers cleared by FDA

Dec. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.